retina subspecialty day

Experts weigh in on Retina Subspecialty Day
Drs. Wykoff, Kim and Spaide summarize day-two of Retina Subspecialty Day at AAO 2017
Drs. Wykoff, Kim and Spaide summarize day-two of Retina Subspecialty Day at AAO 2017
Uveitis updates from Retina Subspecialty Day 2017
OCTA providing two-for-one imaging and practical valueOCT angiography (OCTA) is a revolutionary new tool that adds value to clinical practice. It provides unique insights about retinal and choroidal vasculature compared with conventional OCT along with the advantages of conventional dye-based techniques, said Philip J. Rosenfeld, MD, PhD, at the 2017 Retina Subspecialty Day meeting.
Highlights from Day 2 of Retina Subspecialty Day 2017
Schepens lecturer traces advent, evolution of ophthalmic trialsClinical trials are an indispensable ordeal that are the gold standard for assessing risks and benefits of treatments, said Frederick L. Ferris III, MD.
How to avoid explosive silicone oil injector separationEnsuring correct alignment between the syringe and the cap during silicone oil injection can prevent complications during vitrectomy, said Jay M. Stewart, MD, (San Francisco) presenting during the Retina Subspecialty Day of the 2015 American Academy of Ophthalmology meeting.
DRCRnet Protocol S results provide evidence for retinopathy advanceResults from the Diabetic Retinopathy Clinical Research Network Protocol S provide evidence for the first major advance in the treatment of proliferative diabetic retinopathy (PDR) in more than 40 years, said Jeffrey Gross, MD.
Vitreoretinal surgeon gives thumbs up to heads-up surgeryThere are already several good reasons for ophthalmic surgeons to perform “heads-up” surgery. Further benefits to support its use are anticipated as the technology continues to evolve, said Claus Eckardt, MD, professor of ophthalmology, Klinikum Frankfurt Höchst, Frankfurt, Germany.